FDA’s Ocaliva Blow Spells Changes In Primary Biliary Cholangitis Landscape

Gilead’s Livdelzi, Ipsen’s Iqirvo To Gain

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".